EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study

Lijie Wang, Biao Chen, Jinxian He, Chengbin Lin, Weiyu Shen iD, Wang Lv, Luming Wang, Jian Hu

Clinical and Translational Medicine · 2026-04 · 16 (4)

DOI: 10.1002/ctm2.70642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 29.03.2026. Verfasst von Lijie Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Chemokine CXCL9, Osteopontin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Zhejiang, Research Center for Lung Tumour Diagnosis and Treatment of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐small cell lung cancer (NSCLC) is the predominant lung cancer subtype with high mortality rate. Drug resistance and immune evasion limit its therapeutic outcomes. Specific mechanism of the oncogenic ZFP36L1 in NSCLC remains unclear. Methods scRNA‐seq data were analysed using bioinformatic approaches. Hypoxia‐induced alterations in the macrophage CXCL9:SPP1 ratio were assessed by qRT‐PCR, Western blot (WB), immunofluorescence, flow cytometry and ELISA. Dual‐luciferase reporter and ChIP assays were used to validate ZFP36L1‐mediated transcriptional regulation of SPP1. In a co‐cultivation system of macrophages and NSCLC cells, tumour cell malignancy was evaluated through flow cytometry, CCK‐8, Transwell, colony formation and scratch assays. Patient‐derived organoids co‐cultured with macrophages were analysed via H&E, EdU and CellTiter‐Glo assays for pathological changes, proliferation and viability, as well as qRT‐PCR and WB for the expression of apoptosis‐related proteins. Finally, through a macrophage‐specific ZFP36L1‐knockout mouse model, the function of ZFP36L1 in CXCL9:SPP1 polarity and NSCLC progression was validated in vivo.

Results

Hypoxia induced an imbalanced macrophage CXCL9:SPP1 ratio, with more pro‐tumour SPP1 + macrophages and fewer anti‐tumour CXCL9 + macrophages. Upregulation of ZFP36L1 promoted macrophage polarisation towards the SPP1 + phenotype, which then bound to CD44 on tumour cells to accelerate NSCLC progression.

Conclusion

Under hypoxia, ZFP36L1 transcriptionally regulates SPP1 to reduce the macrophage CXCL9:SPP1 ratio, thereby driving NSCLC malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsChemokine CXCL9OsteopontinTristetraprolinAnimalsHumansMiceDisease ProgressionCell Line, TumorMacrophages

Stichwörter der Autor:innen

CXCL9:SPP1ZFP36L1macrophagenon‐small cell lung cancersingle‐cell transcriptomics

Substanzen

Chemokine CXCL9OsteopontinSPP1 protein, humanTristetraprolinCXCL9 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Thoracic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.

ORCID-Profile: Weiyu Shen

Förderung

  • Key R&D Program of Zhejiang
  • Research Center for Lung Tumour Diagnosis and Treatment of Zhejiang Province

Zitieren

APA

Wang, L., Chen, B., He, J., Lin, C., Shen, W., Lv, W., Wang, L., & Hu, J. (2026). ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study. Clinical and Translational Medicine, 16(4). https://doi.org/10.1002/ctm2.70642

Vancouver

Wang L, Chen B, He J, Lin C, Shen W, Lv W, et al. ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study. Clinical and Translational Medicine. 2026;16(4). doi:10.1002/ctm2.70642

BibTeX
@article{Wang2026,
  author = {Wang, Lijie and Chen, Biao and He, Jinxian and Lin, Chengbin and Shen, Weiyu and Lv, Wang and Wang, Luming and Hu, Jian},
  title = {ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/ctm2.70642}
}
Kostenlos starten →